Semaglutide Helps Prevent Kidney Damage in People with Obesity
-
October 29, 2024
- HealthDayTV HealthDay Reporter
A new study finds semaglutide, the active ingredient in Ozempic and Wegovy, reduced kidney damage by up to 52% in people with obesity.
Health News is provided as a service to San Andreas Pharmacy site users by HealthDay. San Andreas Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.
